Bivariate network meta-analysis for surrogate endpoint evaluation

07/24/2018
by   Sylwia Bujkiewicz, et al.
0

Surrogate endpoints are very important in regulatory decision-making in healthcare, in particular if they can be measured early compared to the long-term final clinical outcome and act as good predictors of clinical benefit. Bivariate meta-analysis methods can be used to evaluate surrogate endpoints and to predict the treatment effect on the final outcome from the treatment effect measured on a surrogate endpoint. However, candidate surrogate endpoints are often imperfect, and the level of association between the treatment effects on the surrogate and final outcomes may vary between treatments. This imposes a limitation on the pairwise methods which do not differentiate between the treatments. We develop bivariate network meta-analysis (bvNMA) methods which combine data on treatment effects on the surrogate and final outcomes, from trials investigating heterogeneous treatment contrasts. The bvNMA methods estimate the effects on both outcomes for all treatment contrasts individually in a single analysis. At the same time, they allow us to model the surrogacy patterns across multiple trials (different populations) within a treatment contrast and across treatment contrasts, thus enabling predictions of the treatment effect on the final outcome for a new study in a new population or investigating a new treatment. Modelling assumptions about the between-studies heterogeneity and the network consistency, and their impact on predictions, are investigated using simulated data and an illustrative example in advanced colorectal cancer. When the strength of the surrogate relationships varies across treatment contrasts, bvNMA has the advantage of identifying treatments for which surrogacy holds, thus leading to better predictions.

READ FULL TEXT

page 1

page 2

page 3

page 4

research
09/09/2018

Combining tumour response and progression free survival as surrogate endpoints for overall survival in advanced colorectal cancer

Progression free survival (PFS) and tumour response (TR) have been inves...
research
05/17/2019

A Bayesian hierarchical meta-analytic method for modelling surrogate relationships that vary across treatment classes

Surrogate endpoints play an important role in drug development when they...
research
09/15/2022

Decision making in cancer: Causal questions require causal answers

Treatment decisions in cancer care are guided by treatment effect estima...
research
08/21/2022

Flexible evaluation of surrogacy in Bayesian adaptive platform studies

Trial level surrogates are useful tools for improving the speed and cost...
research
04/04/2020

A novel approach to bivariate meta-analysis of binary outcomes and its application in the context of surrogate endpoints

Bivariate meta-analysis provides a useful framework for combining inform...
research
12/16/2021

Using Bayesian Evidence Synthesis Methods to Incorporate Real World Evidence in Surrogate Endpoint Evaluation

Objective: Traditionally validation of surrogate endpoints has been carr...
research
03/17/2020

Degree irregularity and rank probability bias in network meta-analysis

Network meta-analysis (NMA) is a statistical technique for the compariso...

Please sign up or login with your details

Forgot password? Click here to reset